Past SARS-CoV-2 Infection Protection Against Reinfection Systematic Review and Meta-Analysis Estimates Estimate GHDx Entry last modified on: Mar 28, 2023
Philippines Demographic and Health Survey 2022 2022 Philippine National Demographic and Health Survey (NDHS) Survey: Cross-sectional - GPS coordinates (GIS) - Household - Individual - Nationally representative - Subnationally representative - Urban-rural representative GHDx Entry last modified on: Aug 24, 2023
Australia Household Impacts of Covid-19 Survey March 2022 Survey: Household - Individual - Interview - Longitudinal - Nationally representative GHDx Entry last modified on: Mar 2, 2023
Long COVID Clinical Phenotypes up to 6 Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms Scientific literature GHDx Entry last modified on: Mar 22, 2024
WHO Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic 2021 - Round 3 Survey GHDx Entry last modified on: Aug 4, 2023
Brazilian Dialysis Survey 2021 Censo Brasileiro de Diálise 2021 Scientific literature GHDx Entry last modified on: Mar 22, 2024
Brazilian Dialysis Survey 2022 Censo Brasileiro de Diálise 2022 Scientific literature GHDx Entry last modified on: Mar 22, 2024
Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Kaiser Family Foundation State COVID-19 Data and Policy Actions 2021-2022 Report: Subnationally representative GHDx Entry last modified on: May 1, 2024
A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity? Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Australia Household Impacts of Covid-19 Survey June 2021 Survey: Household - Individual - Interview - Longitudinal - Nationally representative GHDx Entry last modified on: Mar 2, 2023
Premise Women's Health COVID-19 Health Services Disruption Survey 2021 Survey: Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Federal Ministry of Health Implements Massive Distribution of Personal Protective Equipment to Primary Healthcare Centres in Nigeria Event data GHDx Entry last modified on: May 12, 2022
Premise Child Health COVID-19 Health Services Disruption Survey 2021 Survey: Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Premise Education COVID-19 Health Services Disruption Survey 2021 Survey: Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Premise General Population COVID-19 Health Services Disruption Survey 2021 Survey: Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Premise Infant and Maternal Health COVID-19 Health Services Disruption Survey 2021 Survey: Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Premise Malaria COVID-19 Health Services Disruption Survey 2021 Survey: Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Presence of antibodies to SARS-CoV-2 in Sweden, 26 April - 9 May 2021 Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021 Survey: Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Andhra Pradesh: '59% found to have Covid antibodies in sero-survey' Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022
[Seroprevalence to SARS-CoV-2 among the population of the Belgorod Region amid the COVID-19 epidemic] Scientific literature GHDx Entry last modified on: Mar 14, 2022
Australia Household Impacts of Covid-19 Survey March 2021 Survey: Household - Individual - Interview - Longitudinal - Nationally representative GHDx Entry last modified on: Mar 2, 2023
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint Scientific literature GHDx Entry last modified on: Sep 13, 2022
Portugal National Serological Survey COVID-19 (2nd phase) 2021 Inquérito Serológico Nacional COVID-19 (2.ª fase) (INS COVID-19) Survey: Individual GHDx Entry last modified on: Nov 3, 2022
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021. Survey: Epi surveillance GHDx Entry last modified on: Jul 13, 2022
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors Antistoffen coronavirus bij gemiddeld 18,6% van de donors Epi surveillance GHDx Entry last modified on: May 12, 2022
Jharkhand: 45% of population in 10 districts positive before 2nd wave: Sero survey Survey: Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic. Preprint Scientific literature GHDx Entry last modified on: Apr 8, 2022
COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada. Preprint. Scientific literature GHDx Entry last modified on: Nov 5, 2021
Yemen Supreme National Emergency Committee for COVID-19 Daily Report 2021 Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint Scientific literature GHDx Entry last modified on: Apr 8, 2022
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study Scientific literature GHDx Entry last modified on: May 12, 2022
Seroprevalence of COVID-19 infection among vaccine naïve population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study Scientific literature GHDx Entry last modified on: Jan 31, 2024
United States Behavioral Risk Factor Surveillance System 2021 Survey: Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative GHDx Entry last modified on: Feb 9, 2024
A clinical case definition of post-COVID-19 condition by a Delphi consensus Scientific literature GHDx Entry last modified on: Dec 12, 2023
Germany Digital Vaccination Rate Monitoring for COVID-19 2021-2022 Digitales Impfquotenmonitoring zur COVID-19-Impfung Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Russia Natural Movement of the Population 2022 Естественное Движение Населения В Разрезе Субъектов Российской Федерации За 2022 Года Vital registration: Subnationally representative GHDx Entry last modified on: Jul 21, 2023
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia Scientific literature GHDx Entry last modified on: Jan 31, 2024
Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022 Scientific literature GHDx Entry last modified on: Mar 22, 2024
Evaluation of bacterial coinfections and susceptible antibiotic profiles in hospitalized COVID-19 patients in Koya district, Iraq Scientific literature GHDx Entry last modified on: Mar 22, 2024
Canada - COVID-19 Data in Quebec 2021 Données COVID-19 au Québec Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Compared With Unvaccinated Pregnant Patients Scientific literature GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico Scientific literature GHDx Entry last modified on: Apr 10, 2023
The clinical course and outcomes of SARS-CoV-2 virus infection in children: a 24-week follow-up study in Sulaimaniyah, Iraq Scientific literature GHDx Entry last modified on: Mar 22, 2024
United States COVID-19 Data Tracker Vaccinations 2021-2022 CDC COVID Data Tracker Administrative data: Epi surveillance GHDx Entry last modified on: Aug 24, 2023